Sharps technology, inc. STSS.US Overview

BetaUS StockHealthcare
(No presentation for STSS)

STSS AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

STSS Current Performance

-0.34%

Sharps technology, inc.

-1.83%

Avg of Sector

-0.40%

S&P500

STSS Key Information

STSS Revenue by Segments

STSS Revenue by Segments

STSS Revenue by Segments

Browsing restrictions can be lifted for a fee.

STSS Net Income

STSS Net Income

STSS Net Income

Browsing restrictions can be lifted for a fee.

STSS Cash Flow

STSS Cash Flow

STSS Cash Flow

Browsing restrictions can be lifted for a fee.

STSS Profit Margin

STSS Profit Margin

STSS Profit Margin

Browsing restrictions can be lifted for a fee.

STSS PE Ratio River

STSS PE Ratio River

STSS PE Ratio River

Browsing restrictions can be lifted for a fee.

STSS Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

STSS Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2024Q4
2024Q3
2024Q2
2024Q1

STSS Profile

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Price of STSS

STSS FAQ

  • When is STSS's latest earnings report released?

    The most recent financial report for Sharps technology, inc. (STSS) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating STSS's short-term business performance and financial health. For the latest updates on STSS's earnings releases, visit this page regularly.

  • How much cash does STSS have?

    At the end of the period, Sharps technology, inc. (STSS) held Total Cash and Cash Equivalents of 11.89M, accounting for 0.63 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is STSS's EPS continuing to grow?

    According to the past four quarterly reports, Sharps technology, inc. (STSS)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 38.62. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of STSS?

    Sharps technology, inc. (STSS)'s Free Cash Flow (FCF) for the period is -2.54M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 34.29% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.